Healthy Returns: Eli Lilly’s cholesterol pill impresses in mid-stage trial

Eli Lilly’s cholesterol pill impressed in a mid-stage trial. Meanwhile, Dexcom invested $75 million in Oura.

...

CVS, UnitedHealth, Cigna sue to block FTC case over insulin prices

3 weeks ago

Healthy Returns: Trump’s FDA pick Makary may be a relief for biotech and pharma, analysts say

2 weeks ago

How President-elect Donald Trump's policies may affect investors in these 8 market sectors

2 weeks ago

UnitedHealth Group CEO addresses Brian Thompson death, says health-care system is 'flawed'

2 days ago

We want to boost our ownership of a portfolio stock that just boosted its dividend

2 days ago